Literature DB >> 3335023

Energy substrate utilization in freshly isolated Morris Hepatoma 7777 cells.

J A Mares-Perlman1, E Shrago.   

Abstract

Freshly isolated Morris Hepatoma 7777 cells were prepared for a study of the utilization of palmitate and beta-hydroxybutyrate as metabolic fuels compared to other major energy substrates (glucose and glutamine). These cells were capable of oxidizing both [U-14C]palmitate and beta-[3-14C]hydroxybutyrate although the rates accounted for only 10 +/- 3 (SD) and 9 +/- 4% of total oxygen consumed, respectively; n = 4. Incorporation of [U-14C]glutamine and [U-14C]glucose carbon into 14CO2 made up for 38 +/- 13 and 9 +/- 2% of oxygen consumed by these cells, respectively. The conversion of glucose carbon into lactate was estimated to supply 26 +/- 6% of ATP. Thus, glutamine oxidation and lactate formation from glucose were the major contributors to estimated ATP needs. Conversion of these substrates into lipids was also studied and compared with oxidized products. Incorporation of glucose, glutamine, and beta-hydroxybutyrate into nonsaponifiable lipids and fatty acids was only 6.0 +/- 2.9, 0.8 +/- 0.2 and 17.7 +/- 6.65% (n = 3) of their respective rates of CO2 formation. This suggests that in freshly isolated Morris Hepatoma 7777 cells, citrate export from the mitochondria for cholesterogenesis and lipogenesis is a minor fate of substrate carbon entering the mitochondria for oxidation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3335023

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  Glucose consumption end point in primary histoculture indicates recovery of human tumors from drug treatment.

Authors:  S G Chang; H K Slocum; K Tòth; R M Hoffman; S D Perrapato; R P Huben; Y Rustum
Journal:  In Vitro Cell Dev Biol       Date:  1992 Sep-Oct

2.  Glutamine metabolism in AS-30D hepatoma cells. Evidence for its conversion into lipids via reductive carboxylation.

Authors:  A L Holleran; D A Briscoe; G Fiskum; J K Kelleher
Journal:  Mol Cell Biochem       Date:  1995-11-22       Impact factor: 3.396

Review 3.  A critical review of the role of M2PYK in the Warburg effect.

Authors:  Robert A Harris; Aron W Fenton
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-01-29       Impact factor: 10.680

Review 4.  Mitochondrial membrane cholesterol, the voltage dependent anion channel (VDAC), and the Warburg effect.

Authors:  Andrew M Campbell; Samuel H P Chan
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

5.  Induction of erythroid differentiation in human erythroleukemia cells by depletion of malic enzyme 2.

Authors:  Jian-Guo Ren; Pankaj Seth; Peter Everett; Clary B Clish; Vikas P Sukhatme
Journal:  PLoS One       Date:  2010-09-02       Impact factor: 3.240

6.  Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells.

Authors:  M Board; S Humm; E A Newsholme
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

7.  The vitamin D receptor inhibits the respiratory chain, contributing to the metabolic switch that is essential for cancer cell proliferation.

Authors:  Marco Consiglio; Michele Destefanis; Deborah Morena; Valentina Foglizzo; Mattia Forneris; Gianpiero Pescarmona; Francesca Silvagno
Journal:  PLoS One       Date:  2014-12-29       Impact factor: 3.240

8.  Anorexia-cachexia syndrome in hepatoma tumour-bearing rats requires the area postrema but not vagal afferents and is paralleled by increased MIC-1/GDF15.

Authors:  Tito Borner; Myrtha Arnold; Johan Ruud; Samuel N Breit; Wolfgang Langhans; Thomas A Lutz; Anders Blomqvist; Thomas Riediger
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-12-26       Impact factor: 12.910

9.  Glucose Favors Lipid Anabolic Metabolism in the Invasive Breast Cancer Cell Line MDA-MB-231.

Authors:  Mª Carmen Ocaña; Beatriz Martínez-Poveda; Ana R Quesada; Miguel Ángel Medina
Journal:  Biology (Basel)       Date:  2020-01-10

Review 10.  Ketogenic diet in the treatment of cancer - Where do we stand?

Authors:  Daniela D Weber; Sepideh Aminzadeh-Gohari; Julia Tulipan; Luca Catalano; René G Feichtinger; Barbara Kofler
Journal:  Mol Metab       Date:  2019-07-27       Impact factor: 7.422

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.